About 30 results found for searched term "GLUT" (0.021 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40779 | Recombinant Influenza B Hemagglutinin/HA Protein (HEK293, C-His) | Recombinant Proteins |
| Recombinant Influenza B Hemagglutinin / HA Protein is a homotrimer that recognizes target cells in vertebrates and does so by binding to salivary acid-containing receptors on these cells. When it binds to the target cell, it causes the host inner membrane to fuse with the viral membrane, thereby facilitating the entry of the viral genome into the target cell. | ||
| M2439 | Bemegride | GABA Receptor |
| 3-Ethyl-3-methylglutarimide; Bemegrid | ||
| Bemegride is a central nervous system stimulant and antidote for barbiturate poisoning. | ||
| M3288 | Aminoglutethimide | Others |
| DL-Aminoglutethimide | ||
| Aminoglutethimide is an aromatase inhibitor with IC50 of 10 μM. | ||
| M3611 | D-glutamine | Metabolite/Endogenous Metabolite |
| D-glutamine is a D type stereoisomer of glutamine which is one of the 20 amino acids encoded by the standard genetic code. | ||
| M1601 | Dulaglutide (Activated main chain) | GLP Receptor |
| Dulaglutide (Activated main chain) is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. | ||
| M5380 | Aceglutamide | Autophagy |
| α-N-Acetyl-L-glutamine, N2-Acetylglutamine | ||
| Aceglutamide is a precursor compound to glutamine that improves nerve cell metabolism. | ||
| M5661 | Folic acid | Vitamin |
| Folacin, Vitamin B9, Vitamin M, Pteroylglutamic acid, Folate | ||
| Folic acid, a B vitamin, plays an important role in cell division and in the synthesis of amino acids and nucleic acids like DNA. | ||
| M5682 | Glutathione | Peptides |
| Isethion, Glutathion, Tathion | ||
| Glutathione acts as an antioxidant, a free radical scavenger and a detoxifying agent. It is a tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) present in most mammalian tissue. *The compound is unstable in solutions, freshly prepared is recommended | ||
| M5740 | L-Glutamine | Cell Culture |
| L-Glutamic acid 5-amide | ||
| L-Glutamine (Gln) is one of the 20 amino acids encoded by the standard genetic code and also a major respiratory fuel and substrate for nucleic acid synthesis in mammalian intestinal cells. | ||
| M6285 | Glutaminase C-IN-1 | Glutaminase |
| Compound 968 | ||
| Glutaminase C-IN-1 (Compound 968) is an allosteric inhibitor of Glutaminase C that inhibits cancer cell growth without affecting their normal cellular counterparts. | ||
| M6422 | L-Alanyl-L-glutamine | Cell Culture |
| L-Ala-Gln | ||
| L-Alanyl-L-glutamine (L-Ala-Gln) is a stable form of L-glutamine; commonly used in cell culture. | ||
| M9333 | Phytohemagglutinin | Immunology/Inflammation |
| PHA | ||
| Phytohemagglutinin is a lectin obtained from the red kidney bean that binds to the membranes of T-cells, stimulates metabolic activity and involves inflammatory pathways. Phytohemagglutinin is a T-cell activator. | ||
| M9343 | Glutathione Oxidized | Others |
| GSSG | ||
| Glutathione oxidized is produced by the oxidation of glutathione. | ||
| M9529 | L-Glutamic acid monosodium salt hydrate | NMDA |
| Sodium L-glutamate | ||
| L-Glutamic acid monosodium salt hydrate is also a Kainate receptor, NMDA receptor and quisqualate receptor agonist; an excitatory amino acid neurotransmitter. | ||
| M10035 | Semaglutide | GLP Receptor |
| Rybelsus; Ozempic; NN9535; OG217SC; NNC 0113-0217 | ||
| Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting human GLP-1 analog, it is also a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM). | ||
| M10044 | Albiglutide | GLP Receptor |
| Albiglutide is a recombinant fusion protein consisting of two copies of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36), modified with a glycine substituted for the naturally occurring alanine at position 8 in order to augment resistance to DPP-4. | ||
| M10239 | H-gamma-Glu-Phe-OH | Metabolite/Endogenous Metabolite |
| γ-Glu-Phe; γ-Glutamylphenylalanine | ||
| γ-Glu-Phe (γ-Glutamylphenylalanine) is a γ-3 glutamyl dipeptide synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). | ||
| M10249 | Teduglutide | GLP Receptor |
| ALX 0600; Gattex; Revestive; TAK 633 | ||
| Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. | ||
| M10346 | Glutamic acid (L-Glutamic acid) | Metabolite/Endogenous Metabolite |
| L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). | ||
| M11085 | S-(4-Hydroxybenzyl)glutathione | Others |
| S-(4-Hydroxybenzyl)glutathione is a glutathione derivative. S-(4-Hydroxybenzyl)glutathione inhibits in vitro binding of erythoxylate to cerebral glutamate receptors,IC50 The value is 2 μM. | ||
| M11498 | 2-Ketoglutaric acid | Tyrosinase |
| alpha-ketoglutarate； alpha-ketoglutaric acid；2-oxoglutaric acid | ||
| 2-ketoglutaric acid (alpha-ketoglutaric acid) is an intermediate produced by ATP or GTP in the Krebs cycle. 2-ketoglutaric acid also acts as the main carbon skeleton for nitrogen assimilation. 2-ketoglutaric acid is a reversible inhibitor of Tyrosinase (IC50=15 mM). | ||
| M11531 | L-Pyroglutamic acid | Metabolite/Endogenous Metabolite |
| L-pyroglutamate； 5-Oxoproline；pidolic acid | ||
| L-pyroglutamic acid is a left-handed isomer of Pyroglutamic acid. L-pyroglutamic acid is a bioactive enantiomer in human body. It is a metabolite of the glutathione cycle and can be converted to glutamate by 5-hydroxyprolinase. | ||
| M13972 | Semaglutide TFA | GLP Receptor |
| Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment. | ||
| M14107 | D-α-Hydroxyglutaric acid disodium | ROS |
| Disodium (R)-2-hydroxyglutarate | ||
| D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-hydroxyglutarate) is the principal metabolite accumulating in neurometabolic disease D-2-hydroxyglutaric aciduria. | ||
| M14269 | Ertugliflozin L-pyroglutamic acid | SGLT |
| PF-04971729 L-pyroglutamic acid | ||
| Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. | ||
| M14334 | γ-L-Glutamyl-L-alanine | Metabolite/Endogenous Metabolite |
| γ-L-Glutamyl-L-alanine, composed of gamma-glutamate and alanine, is a proteolytic breakdown product of larger proteins. | ||
| M14636 | (2R)-Octyl-α-hydroxyglutarate | Others |
| (2R)-Octyl-2-HG | ||
| (2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) is a modified form of D-isomer 2-Hydroxyglutarate. | ||
| M14637 | (2S)-Octyl-α-hydroxyglutarate | Others |
| (2S)-Octyl-2-HG | ||
| (2S)-Octyl-α-hydroxyglutarate ((2S)-Octyl-2-HG) is a modified form of S-isomer 2-Hydroxyglutarate. | ||
| M15092 | Phenylacetyl L-Glutamine | Metabolite/Endogenous Metabolite |
| NSC 203800 | ||
| Phenylacetyl L-Glutamine is a colonic microbial metabolite from amino acid fermentation. | ||
| M17731 | 5-Glutinen-3β-ol | Triterpenoids |
| 5-Glutinen-3β-ol | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
